We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $22.85 · 21 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Exclusive - Khatron Ke Khiladi 15: Rithvik Dhanjani opens up about his preparation for the show; says, “T - The Times of India
Exclusive - Khatron Ke Khiladi 15: Rithvik Dhanjani opens up about his preparation for the show; says, “T The Times of India
Khatron Ke Khiladi 15: Rohit Shetty announces new season in his signature style, watch - The Indian Express
Khatron Ke Khiladi 15: Rohit Shetty announces new season in his signature style, watch The Indian Express
Duale Explains KDF Involvement in Laikipia Ebola Facility - Kenyans.co.ke
Duale Explains KDF Involvement in Laikipia Ebola Facility Kenyans.co.ke
Shekaru Uku na Mulkin Uba Sani: Yadda Kaduna ke sauyawa zuwa sabuwa, gangariyar Jiha, Daga Ahmed Maiyaki - Premium Times Hausa
Shekaru Uku na Mulkin Uba Sani: Yadda Kaduna ke sauyawa zuwa sabuwa, gangariyar Jiha, Daga Ahmed Maiyaki Premium Times Hausa
"I Use My Haida Eyes: The History Robes of Jut-ke-nay Hazel Wilson" - CBC
"I Use My Haida Eyes: The History Robes of Jut-ke-nay Hazel Wilson" CBC
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 19. | After market close (AMC) | $2.18 | — | — | $24.46B | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 22. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 08. 15. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 08. 13. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 05. 17. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2025. 05. 16. | UBS | — | Upgrade | Neutral → Buy | — | UBS: Neutral → Buy |
| 2025. 03. 20. | UBS | — | Downgrade | Buy → Neutral | — | UBS: Buy → Neutral |
As of FY2025 · Source: SEC/DART + price data
No holdings data to show.